EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Childhood-Onset Lupus Nephritis in the Era of Triple Therapy and Steroid Minimization

Mohamed S Al Riyami iD, Badria Al Ghaithi, Sulaiman Al Saidi, Anwar Al Omairi iD, Naifain Al Kalbani, Naji Al Dhawi

Children · 15.07.2026 · 13 (7) · 930

DOI: 10.3390/children13070930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Children, online erschienen am 15.07.2026. Verfasst von Mohamed S Al Riyami und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Nephrology Unit, Department of Child Health, Royal Hospital, Muscat PC 111, Oman. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Childhood-onset lupus nephritis (cLN) should no longer be framed as a smaller version of adult lupus nephritis. It is a high-stakes pediatric kidney disease in which immune injury, treatment toxicity, growth, puberty, fertility, adherence, and transition to adult care intersect over decades. Approximately 10–20% of systemic lupus erythematosus begins in childhood, and 40–60% of affected children develop lupus nephritis. Regional cohorts report even higher renal involvement in some populations, including 65–73% among Saudi children with SLE. Contemporary guidance has moved from prolonged high-dose glucocorticoids and cyclophosphamide-dominant treatment toward biopsy-driven, treat-to-target care built around mycophenolic acid analogues, hydroxychloroquine, nephroprotection, rapid steroid tapering, and selected belimumab- or calcineurin-inhibitor-based triple therapy. This Viewpoint argues that the central question in cLN is no longer simply how to induce remission, but how to produce a durable kidney response early enough, with sufficiently low cumulative toxicity, to preserve kidney function and childhood development. Pediatric practice must therefore combine adult trial evidence with child-specific caution, explicit adherence strategies, fertility and growth protection, and structured transition planning. The aim should be efficacy without toxicity: not undertreatment, but intelligent, sustainable, developmentally informed treatment.

Schlagwörter

Stichwörter der Autor:innen

belimumabchildhood-onset lupus nephritisglucocorticoid minimizationkidney biopsymycophenolateobinutuzumabpediatric systemic lupus erythematosustransition caretriple therapyvoclosporin

Autor:innen und Institutionen

  • Pediatric Nephrology Unit, Department of Child Health, Royal Hospital, Muscat PC 111, Oman.
  • Pediatric Nephrology Unit, Department of Child Health, Sultan Qaboos University Hospital, Muscat H5QC+36M, Oman.

ORCID-Profile: Mohamed S Al Riyami, Anwar Al Omairi

Zitieren

APA

Al Riyami, M. S., Al Ghaithi, B., Al Saidi, S., Al Omairi, A., Al Kalbani, N., & Al Dhawi, N. (2026). Childhood-Onset Lupus Nephritis in the Era of Triple Therapy and Steroid Minimization. Children, 13(7), 930. https://doi.org/10.3390/children13070930

Vancouver

Al Riyami MS, Al Ghaithi B, Al Saidi S, Al Omairi A, Al Kalbani N, Al Dhawi N. Childhood-Onset Lupus Nephritis in the Era of Triple Therapy and Steroid Minimization. Children. 2026;13(7):930. doi:10.3390/children13070930

BibTeX
@article{AlRiyami2026,
  author = {Al Riyami, Mohamed S and Al Ghaithi, Badria and Al Saidi, Sulaiman and Al Omairi, Anwar and Al Kalbani, Naifain and Al Dhawi, Naji},
  title = {Childhood-Onset Lupus Nephritis in the Era of Triple Therapy and Steroid Minimization},
  journal = {Children},
  year = {2026},
  volume = {13},
  number = {7},
  pages = {930},
  doi = {10.3390/children13070930}
}
Kostenlos starten →